Skip to content

Effects of Prehabilitation and Early Mobilization for Patients Undergoing Pancreas Surgery.

Effekt av Prehabilitering Och Extra Tidig Mobilisering Efter öppen Pankreas Kirurgi

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03466593
Acronym
PreMob
Enrollment
245
Registered
2018-03-15
Start date
2017-12-18
Completion date
2020-12-31
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreas Cancer

Keywords

Prehabilitation, Recovery, Complications

Brief summary

Open upper gastrointestinal surgery includes surgery in the upper abdomen such as ventricular, duodenal, pancreatic and biliary tract surgery. After upper abdominal surgery there is a risk of gastrointestinal and cardiopulmonary complications. There is currently insufficient knowledge about the effect of prehabilitation and extra early postoperative mobilization in upper pancreatic surgery. This study's aim is to evaluate the effect of prehabilitation and extra early mobilization. The study includes two substudies: 1. A prospective cohort of 75 patients undergoing pancreatic surgery after a prehabilitation program will be compared to 75 historical controls. Primary outcome is postoperative complications. 2. A randomized controlled trial based on 72 patients undergoing pancreatic studying the effect of extra early rehabilitation. The intervention group will be mobilized to bedside, standing or sitting in armchair \<6 hours after surgery, ie 3-4 hours after arrival at the Postoperative Department (PIVA). The control group will be mobilized according to routine i.e. the morning after surgery. Primary outcome is PaO2.

Interventions

OTHERPrehabilitation

Prehabilitation concerning eating, smoking, drinking and physical activity

OTHERRoutine care

Preoperative information

OTHERExtra early mobilization

Mobilization the day of surgery

Mobilization the day after surgery

Sponsors

Göteborg University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

1. A prospective cohort compared to historical controls 2. A randomized, controlled, intervention study.

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients scheduled to undergo pancreatic surgery

Exclusion criteria

in substudy b: * Preoperative injury or disease making it impossible to perform the intervention

Design outcomes

Primary

MeasureTime frameDescription
Postoperative complicationsWhole study period from inclusion to one year after surgeryStandardized complications according to register
PaO2The day before surgery to the first day after surgeryArterial oxygen pressure

Secondary

MeasureTime frameDescription
EORTC-module for fatigueWhole study period from inclusion to one year after surgeryQuality of Life FA-R13 (range 12- 48). Low values correspond to high quality of life
The Postoperative Recovery ProfileWhole study period from inclusion to one year after surgeryQuality of recovery according to Allvin et al. 19 statements which are rated on a four grade scale fron no problem to major problem
EORTC-module genericWhole study period from inclusion to one year after surgeryQuality of life, EORTC-QLQ-C30 (Range 30-124) Low values correspond to high quality of life
SpirometryFrom inclusion (during preoperative information 1-14 days before surgery) to the first postoperative day after the operationVital capacity
Lenght of stayFrom the day before surgery to discharge from the hospital (app 7-14 days)Length of stay at the hospital
Pancreatic cancer disease impact (PACADI) scoreWhole study period from inclusion to one year after surgeryDisease specific questionnaire, 8 statements rated on a visual analogue scale from 0 (no problem) to 10 (worst imaginable problem). Sum score are used for analysis (Range 0-80)
EORTC-module specific for pancreas cancerWhole study period from inclusion to one year after surgeryQuality of life QLQ-OG25 (Range 25- 100). Low values correspond to high quality of life

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026